At the 350th anniversary of the company, Gaby Murphy, EMD Serono’s managing director, gives an insight into the turning point for the affiliate in 2017 with three new Health Canada approvals.
Over the last few months, we have witnessed significant changes within the Canadian pharmaceutical landscape, especially in terms of pricing. How will this impact your operations?
"EMD Serono is one, if not the only company in Canada and globally, that helps to create, improve and prolong life; with our fertility, neuroscience, endocrinology and oncology business units respectively."
